Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Molecular-targeted therapy for motor neuron disease].

Brain and nerve = Shinkei kenkyu no shinpo - 1 Aug 2009

Banno Haruhiko, Katsuno Masahisa, Suzuki Keisuke, Iguchi Yohei, Adachi Hiroaki, Tanaka Fumiaki, Sobue Gen

Abstract excerpt

The mechanisms underlying selective motor neuron degeneration in amyotrophic lateral sclerosis (ALS) remain unknown. There have been several important clinical trials on the treatment of ALS and treatment efficacy studies using mouse (SOD1) models of ALS. The latter revealed that diminished mutan...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Inflammatory Agents, Non-Steroidal
Share to Butyrates
Share to Dyslipidemias

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Free Radical Scavengers

Share to Histone Deacetylase Inhibitors

Share to Nerve Growth Factors

Share to Receptors, Androgen

Share to Superoxide Dismutase-1

Source

Identifiers

PMID: 19697878

Genes

SOD1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19697878-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Molecular-targeted therapy for motor neuron disease].PMID 19697878Read ↗

[Molecular-targeted therapies for spinal and bulbar muscular atrophy].Semantic proximity Read ↗

[Development of therapeutics for spinal and bulbar muscular atrophy (SBMA)].Semantic proximity Read ↗

Amyotrophic lateral sclerosis.Semantic proximity Read ↗

Research advances in amyotrophic lateral sclerosis, 2009 to 2010.Semantic proximity Read ↗

Disease mechanism, biomarker and therapeutics for spinal and bulbar muscular atrophy (SBMA)Semantic proximity Read ↗

SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatmentsSemantic proximity Read ↗

Recent advances in motor neuron disease.Semantic proximity Read ↗

Therapeutic approaches to spinal and bulbar muscular atrophy.Semantic proximity Read ↗

[ALS disease modeling and drug screening using patient-specific iPS cells].Semantic proximity Read ↗

Advances in the Development of Disease-Modifying Treatments for Amyotrophic Lateral Sclerosis.Semantic proximity Read ↗

Extensive phenotypic characterisation of a human TDP-43Q331K transgenic mouse model of amyotrophic lateral sclerosis (ALS)Semantic proximity Read ↗

Spinal and bulbar muscular atrophy: ligand-dependent pathogenesis and therapeutic perspectives.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.